RT Book, Section A1 Isaacs, Claudine A1 Burnstein, Kerry L. A1 Riegel, Anna T. A2 Brunton, Laurence L. A2 Knollmann, Björn C. SR Print(0) ID 1193242962 T1 Hormones, Hormone Receptor Antagonists, and Related Agents in the Therapy of Cancer T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264258079 LK accessanesthesiology.mhmedical.com/content.aspx?aid=1193242962 RD 2024/03/28 AB A Note on Treatment RegimensCancer treatment regimens change to reflect continuous advances in basic and clinical science: new drugs, both small molecules and biologicals; improved methods of targeting and timing of drug delivery; agents with altered pharmacokinetic properties and selectivities; the use of rational multidrug combinations; and greater knowledge of the basic cell biology of tumorigenesis, metastasis, and immune function, among other advances. As a consequence, this chapter presents relatively few detailed treatment regimens; rather, we refer the reader to the web-based resources of the U.S. FDA (drugs@fda) and the NCCN (National Comprehensive Cancer Network). Table 71–1 provides the details and focuses on the complexities of treatment of two cancers.